Molecular genetic analysis of malignant melanomas for aberrations of the wnt signaling pathway genes CTNNB1, APC, ICAT and BTRC

International Journal of Cancer

Volumn 100, Issue 5, 2002, Pages 549-556

  Reifenberger, Julia ^a   Knobbe, Christiane B ^a   Wolter, Marietta ^a   Blaschke, Britta ^a   Schulte, Klaus W ^a   Pietsch, Torsten ^b   Ruzicka, Thomas ^a   Reifenberger, Guido ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

catenin; Adenomatous polyposis coli; ICAT; Loss of heterozygosity; Mutation; Skin tumor

Indexed keywords

APC PROTEIN; BETA CATENIN; BETA TRANSDUCIN REPEAT CONTAINING PROTEIN; CTNNB1 PROTEIN; GENE PRODUCT; INHIBITOR OF BETA CATENIN; TRANSDUCIN; UNCLASSIFIED DRUG;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; MALE; MELANOCYTIC NEVUS; MELANOMA; METASTASIS; MICROSATELLITE MARKER; MISSENSE MUTATION; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; SIGNAL TRANSDUCTION; START CODON;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; BETA-TRANSDUCIN REPEAT-CONTAINING PROTEINS; CELL CYCLE PROTEINS; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MELANOMA; MIDDLE AGED; MUSCLE PROTEINS; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REPRESSOR PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 0037055583     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10512     Document Type: Article

References (43)

1. The incidence of malignant melanoma in the United States: Issues as we approach the 21st century
2. The genetics of cutaneous melanoma
3. Recent advances in melanoma research
4. Genes involved in melanoma: An overview of INK4a and other loci
5. Stabilization of β-catenin by genetic defects in melanoma cell lines
6. Catenins, Wnt signaling and cancer
7. Linking colorectal cancer to Wnt signaling
8. Biochemical interactions in the Wnt pathway
9. Identification of c-MYC as a target of the APC pathway
10. Beta-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression
11. Inhibition of Wnt signaling by ICAT, a novel β-catenin-interacting protein
12. A novel human WD protein, h-β-TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif
13. The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell
14. The human F box protein β-Trcp associates with the Cull/Skp1 complex and regulates the stability of β-catenin
15. More than one way to skin a catenin
16. Frequent nuclear/cytoplasmic localization of β-catenin without exon 3 mutations in malignant melanoma
17. Cytoplasmic and nuclear accumulation of β-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma
18. The BTRC gene, encoding a human F-box/WD40 repeat protein, maps to chromosome 10q24-q25
19. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression
20. Loss of heterozygosity for 10q22-10qter in malignant melanoma progression
21. A genetic model of melanoma tumorigenesis based on allelic losses
22. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas
23. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p
24. INK4a, MTS1) and CDK4 gene have frequent mutations of the retinoblastoma gene
25. Deletion mapping of the short arm of chromosome 1 identifies a common region of deletion distal to D1S496 in human meningiomas
26. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors
27. APC/CTNNB1 (β-catenin) pathway alterations in human prostate cancers
28. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene
29. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes
30. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
31. Frequent association of β-catenin and WT1 mutations in Wilms' tumors
32. Mutational activation of the β-catenin proto-oncogene is a common event in the development of Wilms' tumors
33. Diverse mechanisms of β-catenin deregulation in ovarian endometrioid adenocarcinomas
34. Nuclear accumulation of mutated β-catenin in hepatocellular carcinoma is associated with increased cell proliferation
35. The APC tumour suppressor has a nuclear export function
36. Tumor suppressor PTEN inhibits nuclear accumulation of β-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation
37. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines
38. Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies
39. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation
40. 10q deletions in metastatic cutaneous melanoma
41. Five human genes encoding F-box proteins: Chromosome mapping and analysis in human tumors
42. Small changes in expression affect predisposition to tumorigenesis